about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
0.89
-0.01
(-1.11%)
306.0K
XNAS Volume
XNAS 11 Mar, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Scynexis Inc is scheduled for today, for the purpose of SCYNEXIS Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..